Copyright Reports & Markets. All rights reserved.

Global Cerebral and Tissue Oximetry Devices Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Cerebral and Tissue Oximetry Devices Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Cerebral and Tissue Oximetry Devices Market Size Growth Rate by Product
      • 1.4.2 Portable
      • 1.4.3 Desktop
    • 1.5 Market by End User
      • 1.5.1 Global Cerebral and Tissue Oximetry Devices Market Size Growth Rate by End User
      • 1.5.2 Clinicals
      • 1.5.3 Hospitials
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Cerebral and Tissue Oximetry Devices Market Size
      • 2.1.1 Global Cerebral and Tissue Oximetry Devices Revenue 2014-2025
      • 2.1.2 Global Cerebral and Tissue Oximetry Devices Sales 2014-2025
    • 2.2 Cerebral and Tissue Oximetry Devices Growth Rate by Regions
      • 2.2.1 Global Cerebral and Tissue Oximetry Devices Sales by Regions
      • 2.2.2 Global Cerebral and Tissue Oximetry Devices Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Cerebral and Tissue Oximetry Devices Sales by Manufacturers
      • 3.1.1 Cerebral and Tissue Oximetry Devices Sales by Manufacturers
      • 3.1.2 Cerebral and Tissue Oximetry Devices Sales Market Share by Manufacturers
      • 3.1.3 Global Cerebral and Tissue Oximetry Devices Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cerebral and Tissue Oximetry Devices Revenue by Manufacturers
      • 3.2.1 Cerebral and Tissue Oximetry Devices Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cerebral and Tissue Oximetry Devices Revenue Share by Manufacturers (2014-2019)
    • 3.3 Cerebral and Tissue Oximetry Devices Price by Manufacturers
    • 3.4 Cerebral and Tissue Oximetry Devices Manufacturing Base Distribution, Product Types
      • 3.4.1 Cerebral and Tissue Oximetry Devices Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Cerebral and Tissue Oximetry Devices Product Type
      • 3.4.3 Date of International Manufacturers Enter into Cerebral and Tissue Oximetry Devices Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Cerebral and Tissue Oximetry Devices Sales by Product
    • 4.2 Global Cerebral and Tissue Oximetry Devices Revenue by Product
    • 4.3 Cerebral and Tissue Oximetry Devices Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Cerebral and Tissue Oximetry Devices Breakdown Data by End User

    6 North America

    • 6.1 North America Cerebral and Tissue Oximetry Devices by Countries
      • 6.1.1 North America Cerebral and Tissue Oximetry Devices Sales by Countries
      • 6.1.2 North America Cerebral and Tissue Oximetry Devices Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Cerebral and Tissue Oximetry Devices by Product
    • 6.3 North America Cerebral and Tissue Oximetry Devices by End User

    7 Europe

    • 7.1 Europe Cerebral and Tissue Oximetry Devices by Countries
      • 7.1.1 Europe Cerebral and Tissue Oximetry Devices Sales by Countries
      • 7.1.2 Europe Cerebral and Tissue Oximetry Devices Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Cerebral and Tissue Oximetry Devices by Product
    • 7.3 Europe Cerebral and Tissue Oximetry Devices by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Cerebral and Tissue Oximetry Devices by Countries
      • 8.1.1 Asia Pacific Cerebral and Tissue Oximetry Devices Sales by Countries
      • 8.1.2 Asia Pacific Cerebral and Tissue Oximetry Devices Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Cerebral and Tissue Oximetry Devices by Product
    • 8.3 Asia Pacific Cerebral and Tissue Oximetry Devices by End User

    9 Central & South America

    • 9.1 Central & South America Cerebral and Tissue Oximetry Devices by Countries
      • 9.1.1 Central & South America Cerebral and Tissue Oximetry Devices Sales by Countries
      • 9.1.2 Central & South America Cerebral and Tissue Oximetry Devices Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Cerebral and Tissue Oximetry Devices by Product
    • 9.3 Central & South America Cerebral and Tissue Oximetry Devices by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Cerebral and Tissue Oximetry Devices by Countries
      • 10.1.1 Middle East and Africa Cerebral and Tissue Oximetry Devices Sales by Countries
      • 10.1.2 Middle East and Africa Cerebral and Tissue Oximetry Devices Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Cerebral and Tissue Oximetry Devices by Product
    • 10.3 Middle East and Africa Cerebral and Tissue Oximetry Devices by End User

    11 Company Profiles

    • 11.1 CAS Medical Systems
      • 11.1.1 CAS Medical Systems Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 CAS Medical Systems Cerebral and Tissue Oximetry Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 CAS Medical Systems Cerebral and Tissue Oximetry Devices Products Offered
      • 11.1.5 CAS Medical Systems Recent Development
    • 11.2 Masimo
      • 11.2.1 Masimo Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Masimo Cerebral and Tissue Oximetry Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Masimo Cerebral and Tissue Oximetry Devices Products Offered
      • 11.2.5 Masimo Recent Development
    • 11.3 Medtronic
      • 11.3.1 Medtronic Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Medtronic Cerebral and Tissue Oximetry Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Medtronic Cerebral and Tissue Oximetry Devices Products Offered
      • 11.3.5 Medtronic Recent Development
    • 11.4 Nonin Medical
      • 11.4.1 Nonin Medical Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Nonin Medical Cerebral and Tissue Oximetry Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Nonin Medical Cerebral and Tissue Oximetry Devices Products Offered
      • 11.4.5 Nonin Medical Recent Development
    • 11.5 Hamamatsu Photonics
      • 11.5.1 Hamamatsu Photonics Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Hamamatsu Photonics Cerebral and Tissue Oximetry Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Hamamatsu Photonics Cerebral and Tissue Oximetry Devices Products Offered
      • 11.5.5 Hamamatsu Photonics Recent Development
    • 11.6 Hutchinson Technology
      • 11.6.1 Hutchinson Technology Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Hutchinson Technology Cerebral and Tissue Oximetry Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Hutchinson Technology Cerebral and Tissue Oximetry Devices Products Offered
      • 11.6.5 Hutchinson Technology Recent Development
    • 11.7 HyperMed
      • 11.7.1 HyperMed Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 HyperMed Cerebral and Tissue Oximetry Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 HyperMed Cerebral and Tissue Oximetry Devices Products Offered
      • 11.7.5 HyperMed Recent Development
    • 11.8 ISS
      • 11.8.1 ISS Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 ISS Cerebral and Tissue Oximetry Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 ISS Cerebral and Tissue Oximetry Devices Products Offered
      • 11.8.5 ISS Recent Development
    • 11.9 Moor Instruments
      • 11.9.1 Moor Instruments Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Moor Instruments Cerebral and Tissue Oximetry Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Moor Instruments Cerebral and Tissue Oximetry Devices Products Offered
      • 11.9.5 Moor Instruments Recent Development
    • 11.10 Ornim Medical
      • 11.10.1 Ornim Medical Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Ornim Medical Cerebral and Tissue Oximetry Devices Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Ornim Medical Cerebral and Tissue Oximetry Devices Products Offered
      • 11.10.5 Ornim Medical Recent Development
    • 11.11 Reflectance Medical
    • 11.12 Spectros
    • 11.13 ViOptix

    12 Future Forecast

    • 12.1 Cerebral and Tissue Oximetry Devices Market Forecast by Regions
      • 12.1.1 Global Cerebral and Tissue Oximetry Devices Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Cerebral and Tissue Oximetry Devices Revenue Forecast by Regions 2019-2025
    • 12.2 Cerebral and Tissue Oximetry Devices Market Forecast by Product
      • 12.2.1 Global Cerebral and Tissue Oximetry Devices Sales Forecast by Product 2019-2025
      • 12.2.2 Global Cerebral and Tissue Oximetry Devices Revenue Forecast by Product 2019-2025
    • 12.3 Cerebral and Tissue Oximetry Devices Market Forecast by End User
    • 12.4 North America Cerebral and Tissue Oximetry Devices Forecast
    • 12.5 Europe Cerebral and Tissue Oximetry Devices Forecast
    • 12.6 Asia Pacific Cerebral and Tissue Oximetry Devices Forecast
    • 12.7 Central & South America Cerebral and Tissue Oximetry Devices Forecast
    • 12.8 Middle East and Africa Cerebral and Tissue Oximetry Devices Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Cerebral and Tissue Oximetry Devices Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Cerebral and tissue oximeters help physicians obtain non-invasive, continuous measures of cerebral oxygenation levels in the cerebral tissues.
      The Americas dominated the global cerebral and tissue oximetry market and are expected to maintain the market leader statu in the forecast period. 
      The global Cerebral and Tissue Oximetry Devices market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cerebral and Tissue Oximetry Devices market based on company, product type, end user and key regions.

      This report studies the global market size of Cerebral and Tissue Oximetry Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cerebral and Tissue Oximetry Devices in these regions.
      This research report categorizes the global Cerebral and Tissue Oximetry Devices market by top players/brands, region, type and end user. This report also studies the global Cerebral and Tissue Oximetry Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      CAS Medical Systems
      Masimo
      Medtronic
      Nonin Medical
      Hamamatsu Photonics
      Hutchinson Technology
      HyperMed
      ISS
      Moor Instruments
      Ornim Medical
      Reflectance Medical
      Spectros
      ViOptix

      Market size by Product
      Portable
      Desktop
      Market size by End User
      Clinicals
      Hospitials
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Cerebral and Tissue Oximetry Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Cerebral and Tissue Oximetry Devices market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Cerebral and Tissue Oximetry Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Cerebral and Tissue Oximetry Devices submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Cerebral and Tissue Oximetry Devices are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cerebral and Tissue Oximetry Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now